Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Morphine Sulfate Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Amphastar Pharmaceuticals, Inc. (Reverified 05/14/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 76329-1912-1) | Available |
Fresenius Kabi USA, LLC (Revised 05/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 63323-452-01) | Unavailable | Backordered. Next release May 2024. | Delay in shipping of the drug |
| Injection, 4 mg/1 mL (NDC 63323-454-01) | Unavailable | Backordered. Next release May 2024. | Demand increase for the drug |
| Injection, 5 mg/1 mL (NDC 63323-455-01) | Available | Check wholesalers for inventory | |
| Injection, 10 mg/1 mL (NDC 63323-451-01) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Injection, 2 mg/1 mL (NDC 76045-004-11) | Available | Check wholesalers for inventory | |
| Injection, 4 mg/1 mL (NDC 76045-005-11) | Available | Check wholesalers for inventory |
Hikma Pharmaceuticals USA, Inc. (Revised 05/17/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Morphine Sulfate Injection, USP, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Available | ||
| Morphine Sulfate Injection, USP, Injection, 8 mg/1 mL (NDC 0641-6126-25) | Available | ||
| Morphine Sulfate Injection, USP, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Available | ||
| Duramorph (Morphine Sulfate Injection, USP), Injection, 1 mg/1 mL (NDC 0641-6019-10) | Available | ||
| Duramorph (Morphine Sulfate Injection, USP), Injection, .5 mg/1 mL (NDC 0641-6020-10) | Available | ||
| Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Available | ||
| Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Available |
Hospira, Inc., a Pfizer Company (Revised 05/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-01) | Limited Availability | Limited Supply Available. Next Delivery: May 2024; Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-01) | Limited Availability | Limited Supply Available. Next Delivery: June 2024; Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0409-1892-01) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0409-1893-01) | Limited Availability | Limited Availability. Next Delivery: October 2024; Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-03) | Unavailable | Next Delivery: September 2025; Estimated Recovery: December 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05) | Unavailable | Next Delivery and Estimated Recovery: December 2024; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
Piramal Critical Care Inc. (Revised 04/30/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Mitigo (Morphine Sulfate Injection, USP), Injection, 200 mg/20 mL (NDC 66794-160-02) | Available | ||
| Mitigo (Morphine Sulfate Injection, USP), Injection, 500 mg/20 mL (NDC 66794-162-02) | Available |